Increased plasma LPL activity has been detected in ASD [61] and an analysis of dyslipidemia in ASD identified sex-differentially expressed, neurodevelopmentally co-regulated, ASD segregating deleterious variants of LPL [65]. This evidence concerns the gene LPL and metabolic syndrome.